解剖学报 ›› 2016, Vol. 47 ›› Issue (4): 493-501.doi: 10.16098/j.issn.0529-1356.2016.04.010
明海霞1,2,5 陈彦文3 张帆4,5 王强3 李杨2,5 郭超3 胡永浩1*
MING Hai-xia 1,2,5 CHEN Yan-wen3 ZHANG Fan 4,5 WANG Qiang3 LI Yang 2,5 GUO Chao3 HU Yong-hao 1*
1. College of Animal Medine, Gansu Agricultural University, Lanzhou 730070, China; 2. Physical Teaching and Research Section, Laboratory of Gansu Province Chinese Medicine Pharmacology and Toxicology, Gansu University of Chinese Medicine, Lanzhou 730000, China; 3. Anatomy Teaching and Research section, Laboratory of Gansu Province Chinese Medicine Pharmacology and Toxicology, Gansu University of Chinese Medicine, Lanzhou 730000, China; 4. Biology Teaching and Research Section, Laboratory of Gansu Province Chinese Medicine Pharmacology and Toxicology, Gansu University of Chinese Medicine, Gansu Lanzhou 730000, China; 5. ProvincialLevel Key Laboratory for Molecular Medicine of Major Diseases and the Prevention and Treatment with Traditional Chinese Medicine Research in Gansu Colleges and Universities, Lanzhou 730000, China
摘要:
目的 观察黄芪多糖(APS)联合顺铂(DDP)对小鼠Lewis肺癌细胞肺转移、核因子(NF)-κB、P38、P53及Caspase-9表达的影响。方法 将90只Lewis小鼠随机分为模型组、顺铂组(6mg/kg DDP)、APS组(50、100、200)mg/kg,联合用药组[1/2 DDP+APS,即:(3+25、3+50、3+100)mg/kg]。各组均于造模第2天起用药,APS每日1次,DDP每周1次,连续20d。观察肿瘤肺转移情况,采用Real-time PCR法和Western blotting法检测肿瘤组织中NF-κB、P38、P65蛋白和基因,并用免疫组织化学检测Caspase-9的表达。 结果 与模型组相比,各治疗组均可降低肺转移灶数目(P<0.05或P<0.01);除P38外,APS中、高剂量组可使小鼠Lewis肺癌组织中NF-κB p65、P53表达降低,Caspase-9表达增高;联合用药高剂量组作用则接近DDP组。结论 APS可抑制小鼠Lewis肺癌细胞的转移,抑制NF-κB和丝裂原活化蛋白激酶(MAPK)信号通路的激活,这可能是其抑制肿瘤转移的机制之一;APS与减半剂量的DDP铂类化疗药物联合使用时,作用增强,APS对DDP有增效减毒作用。